| Baseline Characteristic |
No. of Patients |
% |
Baseline SUVmax |
Baseline NLR |
| |
|
|
Median |
Pvalue |
Median |
Pvalue |
| Age |
| ≤50 |
50 |
57 |
6.3 |
0.456 |
1.9 |
0.646 |
| >50 |
37 |
43 |
6.9 |
|
1.8 |
| Tumor phenotype |
| Luminal A |
25 |
29 |
4.3 |
0.332 |
1.9 |
0.432 |
| Luminal B |
24 |
28 |
4.9 |
0.344 |
1.8 |
0.478 |
| Luminal B like |
15 |
17 |
5.4 |
0.235 |
2 |
0.368 |
| Her2 neu positive |
13 |
15 |
9.1 |
0.02* |
3.8 |
0.0416* |
| Triple negative |
10 |
1 |
10.8 |
0.01* |
2.3 |
0.07 |
| Histology |
| Ductal |
78 |
90 |
6.2 |
|
1.8 |
0.345 |
| Lobular |
6 |
7 |
5.7 |
0.443 |
1.9 |
| Other |
3 |
3 |
7.1 |
|
2 |
| Grade |
| 1 |
0 |
|
|
|
|
0.332 |
| 2 |
7 |
8 |
7 |
|
1.9 |
| 3 |
80 |
92 |
9.8 |
0. 01* |
2.8 |
| Proliferation index |
| Ki 67% ≤ 14% |
17 |
20 |
3.7 |
|
1.98 |
0.654 |
| Ki 67% ≥ 14% |
70 |
80 |
8.3 |
0. 01* |
2.6 |
| Metastatic sites |
| Visceral |
41 |
47 |
9.8 |
0.005* |
3.8 |
0.05* |
| Bone only |
46 |
53 |
3.8 |
|
0.93 |
|
